We are live on ! Find out more
BIOA

BioAmber Inc.
BIOA

Delisted

BIOA was delisted on the 8th of February, 2018.

2 hedge funds and large institutions have $7K invested in BioAmber Inc. in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 42 (-2)

99% less capital invested

Capital invested by funds: $756K → $7K (-$749K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FMBTD
1
First Midwest Bank Trust Division
Illinois
$6K
LCS
2
Levin Capital Strategies
New York
$1K -$500 -5,600 -33%
NIPH
3
NN Investment Partners Holdings
Netherlands
-$382K -8,116,302 Closed
SM
4
Sabby Management
Florida
-$368K -7,819,887 Closed

BIOA Hedge Fund Activity: Q2 2018 in Review

2 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q2 2018, worth a combined $7K — down 99% from $756K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BIOA and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was NN Investment Partners Holdings, exiting entirely with an estimated $382K sold.

  • 2 institutional investors held BioAmber Inc. (BIOA) as of Q2 2018, down from 4 in Q1 2018.
  • Funds reported $7K of BioAmber Inc. stock for Q2 2018, down 99% quarter-over-quarter.
  • 0 funds opened new BioAmber Inc. positions in Q2 2018 and 2 closed out, a net change of -2 holders.
  • The largest BioAmber Inc. seller in Q2 2018 was NN Investment Partners Holdings, an estimated $382K sold.

Based on aggregated 13F filings for Q2 2018.